Progesterone-induced-blocking factor 1 is a protein that in humans is encoded by the PIBF1gene. It has been shown to localize to the centrosome and has also been named CEP90.
↑"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑Rozenblum E, Vahteristo P, Sandberg T, Bergthorsson JT, Syrjakoski K, Weaver D, etal. (April 2002). "A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes". Human Genetics. 110 (2): 111–121. doi:10.1007/s00439-001-0646-6. PMID11935316. S2CID21371347.
↑Kim K, Rhee K (February 2011). "The pericentriolar satellite protein CEP90 is crucial for integrity of the mitotic spindle pole". Journal of Cell Science. 124 (Pt 3): 338–347. doi:10.1242/jcs.078329. PMID21224392. S2CID12306606.
Szekeres-Bartho J, Barakonyi A, Par G, Polgar B, Palkovics T, Szereday L (June 2001). "Progesterone as an immunomodulatory molecule". International Immunopharmacology. 1 (6): 1037–1048. doi:10.1016/S1567-5769(01)00035-2. PMID11407300.
Szekeres-Bartho J, Varga P, Pejtsik B (1990). "ELISA test for the detection of an immunological blocking factor in human pregnancy serum". Journal of Reproductive Immunology. 16 (1): 19–29. doi:10.1016/0165-0378(89)90003-X. PMID2600930.
Szekeres-Bartho J, Faust Z, Varga P (1996). "The expression of a progesterone-induced immunomodulatory protein in pregnancy lymphocytes". American Journal of Reproductive Immunology. 34 (6). New York: 342–348. doi:10.1111/j.1600-0897.1995.tb00962.x. PMID8607938. S2CID6397686.
Check JH, Arwitz M, Gross J, Peymer M, Szekeres-Bartho J (January 1997). "Lymphocyte immunotherapy (LI) increases serum levels of progesterone induced blocking factor (PIBF)". American Journal of Reproductive Immunology. 37 (1). New York: 17–20. doi:10.1111/j.1600-0897.1997.tb00188.x. PMID9138449. S2CID19773974.
Check JH, Arwitz M, Gross J, Szekeres-Bartho J, Wu CH (July 1997). "Evidence that the expression of progesterone-induced blocking factor by maternal T-lymphocytes is positively correlated with conception". American Journal of Reproductive Immunology. 38 (1). New York: 6–8. doi:10.1111/j.1600-0897.1997.tb00269.x. PMID9266004. S2CID26240194.
Harrington JJ, Sherf B, Rundlett S, Jackson PD, Perry R, Cain S, etal. (May 2001). "Creation of genome-wide protein expression libraries using random activation of gene expression". Nature Biotechnology. 19 (5): 440–445. doi:10.1038/88107. PMID11329013. S2CID25064683.
Kozma N, Halasz M, Palkovics T, Szekeres-Bartho J (2006). "The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca". American Journal of Reproductive Immunology. 55 (2). New York: 122–129. doi:10.1111/j.1600-0897.2005.00337.x. PMID16433831. S2CID32668565.